Roche

Pharmaceutical giant Roche has announced it is discontinuing two major human clinical trials into the anti-Alzheimer’s drug crenezumab. The decision comes after many similar treatments have recently failed in human trials adding to a growing doubt over how to best tackle Alzheimer’s disease.